Trade name
Quinine Dihydrochloride (Phebra)
Strength
60 mg/mL (volume: 10 mL)
IV administration
Dilute to 2 mg/mL and give over 4 hours.
Maximum rate of administration: 0.5 mg/minute.
Intensive Care setting only:
A loading dose of 7 mg/kg may be given over 30 minutes.
Maximum concentration if necessary: 30 mg/mL preferably via a central line.
Other routes of administration
IM: Not recommended due to safety and efficacy concerns. Use only as a last resort if oral and IV are not possible.
SC: Not recommended.
Compatible IV fluids
Glucose 5% is the preferred diluent.
Sodium chloride 0.9%
Additional information
Extravasation risk.
Use only when facilities for cardiac monitoring and cardio-respiratory resuscitation exist.
Rapid administration may cause hypotension and arrhythmias. Reduce rate of infusion if dysrhythmia occurs.
Administration may cause hypoglycaemia. Monitor blood glucose levels.
Therapeutic Drug Monitoring may be required; refer to local guidelines.
Solution should be clear and colourless or slightly yellow.
Discard any unused vial contents.
Protect from light during storage.